Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Web of Science ,
Scopus
Authors
Kudriavtsev A.V., Vakhrusheva A. V., Kryuchkov N.A., Frolova M. E., Blagodatskikh K.A., Ivanishin T. V., Djonovic M., * Romanovskaya-Romanko E.A., Kovalenko A.N., * Lioznov D.A., * Zubkova T.G., Teplykh S.V., Oseshnyuk R.A., * Stukova M.A., * Krasilnikov I.V.
Publication type
Journal article
Indexed in
Web of Science ,
Scopus Info:
Published in
Vaccines
Year of publication
2023
Volume
11
Number
2
Pages
326